Details of the Drug Formulations

General Information of Drug (ID: DMIMF8J)

Drug Name
Risdiplam Drug Info
Synonyms
UNII-76RS4S2ET1; 76RS4S2ET1; 1825352-65-5; Risdiplam [INN]; SCHEMBL17260852; EX-A2074; RG-7916; HY-109101; RO7034067; CS-0039501; 4H-Pyrido(1,2-a)pyrimidin-4-one, 7-(4,7-diazaspiro(2.5)oct-7-yl)-2-(2,8-dimethylimidazo(1,2-b)pyridazin-6-yl)-; 2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(4,7-diazaspiro[2.5]octan-7-yl)-4H-pyrido[1,2-a]pyrimidin-4-one
Indication
Disease Entry ICD 11 Status REF
Spinal muscular atrophy 8B61 Approved [1]
Cross-matching ID
PubChem CID
118513932
CAS Number
1825352-65-5
TTD ID
D0N5MH
INTEDE ID
DR1823
ACDINA ID
D01397

Full List of Drug Formulations Containing This Drug

Risdiplam 0.75 mg/ml powder
Company Formulation ID FDA Description
Genentech F23278 Ascorbic Acid; Disodium Edetate Dihydrate; Isomalt; Mannitol; Polyethylene Glycol 6000; Sodium Benzoate; Strawberry Flavor; Sucralose; Tartaric Acid
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020